Document
IPR2017-00190, No. 1619-339 Exhibit - Exhibit 1619a ¿¿¿Physicians Pharmaceutical Sales Representatives interactions and Conflict of Interest Challenges and Solutions,¿¿¿ AR Patwardhan, The...
Cite Document
IPR2017-00190, No. 1619-339 Exhibit - Exhibit 1619a ¿¿¿Physicians Pharmaceutical Sales Representatives interactions and Conflict of Interest Challenges and Solutions,¿¿¿ AR Patwardhan, The Journal o
+ More Snippets
Document
IPR2017-00190, No. 1522-329 Exhibit - Exhibit 1522a Theodore Rosen et al, Seminars in Cutaneous Medicine and Surgery Onychomycosis Diagnosis, Treatment, and Prevention Strategies S...
Cite Document
IPR2017-00190, No. 1522-329 Exhibit - Exhibit 1522a Theodore Rosen et al, Seminars in Cutaneous Medicine and Surgery Onychomycosis Diagnosis, Treatment, and Prevention Strategies Supp 3, 35 3S S51
+ More Snippets
Document
IPR2017-00190, No. 2007-53 Exhibit - Kaken Exhibit 2007 (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00190, No. 2007-53 Exhibit - Kaken Exhibit 2007 (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1658-307 Exhibit - Thomas Reuters StreetEvents, Edited Transcript, VRXTO ¿¿¿ Q1 2015 Valeant Pharmaceuticals International Inc Earnings Call (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1658-307 Exhibit - Thomas Reuters StreetEvents, Edited Transcript, VRXTO ¿¿¿ Q1 2015 Valeant Pharmaceuticals International Inc Earnings Call (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1542-191 Exhibit - Suit Alleges Valeant Ran Secret Prescription Refill Scam (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1542-191 Exhibit - Suit Alleges Valeant Ran Secret Prescription Refill Scam (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1648-297 Exhibit - onsolidated Financial Results for Fiscal 2015 Reference Data of Financial Statements for the 3Q of Fiscal 2015 (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1648-297 Exhibit - onsolidated Financial Results for Fiscal 2015 Reference Data of Financial Statements for the 3Q of Fiscal 2015 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1010-10 Exhibit - Publication of PCTJP0004617 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1010-10 Exhibit - Publication of PCTJP0004617 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1030-30 Exhibit - J of the European Academy of Dermatology and Venereology 4 Supp 11995 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1030-30 Exhibit - J of the European Academy of Dermatology and Venereology 4 Supp 11995 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1545-194 Exhibit - Valeant Slumps Again After Rebutting Critical Report (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1545-194 Exhibit - Valeant Slumps Again After Rebutting Critical Report (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1610-259 Exhibit - Valeant Pharmaceuticals International, Inc 2015 Financial Guidance Conference Call Presentation, dated January 8, 2015 (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1610-259 Exhibit - Valeant Pharmaceuticals International, Inc 2015 Financial Guidance Conference Call Presentation, dated January 8, 2015 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1641-290 Exhibit - Top 200 Brand Name Drugs by Retail Sales in 2003 (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1641-290 Exhibit - Top 200 Brand Name Drugs by Retail Sales in 2003 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2072-118 Exhibit - Kaken Exhibit 2072 (P.T.A.B. Aug. 1, 2017)
Cite Document
IPR2017-00190, No. 2072-118 Exhibit - Kaken Exhibit 2072 (P.T.A.B. Aug. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2014-60 Exhibit - Kaken Exhibit 2014 (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00190, No. 2014-60 Exhibit - Kaken Exhibit 2014 (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1609-258 Exhibit - Pharma is the 7th Largest Ad Category in the US at $64 billion Last Year (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1609-258 Exhibit - Pharma is the 7th Largest Ad Category in the US at $64 billion Last Year (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1551-200 Exhibit - Yahoo Finance, Valeant Pharmaceuticals International, Inc, Stock Price Historical Values Daily, dated from October 1, 2015 through December 31, 2015 ...
Cite Document
IPR2017-00190, No. 1551-200 Exhibit - Yahoo Finance, Valeant Pharmaceuticals International, Inc, Stock Price Historical Values Daily, dated from October 1, 2015 through December 31, 2015 (P.T.A.B. Nov
+ More Snippets